COST-EFFECTIVENESS ANALYSIS OF AN ADJUSTED POLYGENIC RISK SCORE IN CARDIOVASCULAR DISEASE PREVENTION

被引：0
|
作者：
Hatziandreou, E. [1 ]
Panagiotou, N. [1 ]
机构：
[1] IDNA Genom, Attica, Greece
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE159
引用
收藏
页码：S81 / S81
页数：1
相关论文
共 50 条
  • [41] The polypill in the primary prevention of cardiovascular disease: cost-effectiveness in the Dutch population
    van Gils, Paul F.
    Over, Eelco A. B.
    Hamberg-van Reenen, Heleen H.
    de Wit, G. Ardine
    van den Berg, Matthijs
    Schuit, Albertine J.
    Engelfriet, Peter M.
    [J]. BMJ OPEN, 2011, 1 (02):
  • [42] Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study
    Cobiac, Linda J.
    Magnus, Anne
    Barendregt, Jan J.
    Carter, Rob
    Vos, Theo
    [J]. BMC PUBLIC HEALTH, 2012, 12
  • [43] THE POLYPILL IN THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE: COST-EFFECTIVENESS IN THE DUTCH POPULATION
    Van Gils, P. F.
    Hamberg-Van Reenen, H. H.
    Over, E.
    de Wit, G. A.
    van den Berg, M.
    Schuit, A. J.
    Engelfriet, P. M.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A381 - A381
  • [44] Cost-effectiveness of cardiovascular prevention programs in Spain
    Plans-Rubio, P
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 1998, 14 (02) : 320 - 330
  • [45] Polygenic risk-tailored screening for prostate cancer: A cost-effectiveness analysis
    Callender, Thomas
    Emberton, Mark
    Morris, Steve
    Eeles, Ros
    Kote-Jarai, Zsofia
    Pharoah, Paul
    Pashayan, Nora
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [46] Cost-Effectiveness of Cardiovascular Disease Spending
    Miller, George
    Cohen, Joshua T.
    Roehrig, Charles
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (20) : 2123 - 2124
  • [47] Cost-effectiveness of statins in the primary prevention of cardiovascular disease: a systematic review and economic analysis for Belgium
    Neyt, Mattias
    De laet, Chris
    Van Brabandt, Hans
    Franco, Oscar
    Ramaekers, Dirk
    [J]. ACTA CARDIOLOGICA, 2009, 64 (01) : 1 - 10
  • [48] Statins for atherosclerotic cardiovascular disease prevention in people living with HIV in Thailand: a cost-effectiveness analysis
    Boettiger, David C.
    Newall, Anthony T.
    Chattranukulchai, Pairoj
    Chaiwarith, Romanee
    Khusuwan, Suwimon
    Avihingsanon, Anchalee
    Phillips, Andrew
    Bendavid, Eran
    Law, Matthew G.
    Kahn, James G.
    Ross, Jeremy
    Bautista-Arredondo, Sergio
    Kiertiburanakul, Sasisopin
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23
  • [49] COST-EFFECTIVENESS ANALYSIS OF THE USE OF STATINS IN PREVENTION OF CARDIOVASCULAR EVENTS IN COLOMBIA
    Mould, J.
    Ordonez, J.
    Gutierrez-Ardila, M., V
    Vargas Zea, N.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A666 - A666
  • [50] Cost-effectiveness analysis of interventions to prevent cardiovascular disease in Vietnam
    Duc Anh Ha
    Chisholm, Dan
    [J]. HEALTH POLICY AND PLANNING, 2011, 26 (03) : 210 - 222
12345